IMS MAXIMS Announced as Finalist in HealthInvestor Awards

IMS MAXIMSIMS MAXIMS has announced that it has been shortlisted as a finalist in the 'Technology provider of the year' category for the HealthInvestor Awards 2013. The prestigious HealthInvestor awards recognise innovation in the healthcare sector and celebrate excellence in a wide range of categories from complex care provider of the year to diagnostics provider of the year. In each of the 22 categories an independent panel of high profile judges will look for organisations and individuals that have made an outstanding contribution to healthcare throughout 2012.

IMS MAXIMS has been shortlisted for the award after the company demonstrated numerous initiatives and partnerships aimed at improving the quality of patient care, increasing efficiency and enhancing the uptake of healthcare IT across the health service.

Among the initiatives was the launch of the Electronic Patient Information Centre (E.P.I.Centre) campaign, which aims to promote innovation across health and social care through the development of a physical and virtual centre to share best practice around healthcare technology.

In addition, IMS MAXIMS announced a 'first of its kind' partnership with St Helen’s and Knowsley Teaching Hospitals NHS Trust, to offer the NHS a fully integrated electronic patient record solution hosted within an NHS trust.

Shane Tickell, CEO of IMS MAXIMS said: "Being shortlisted as a finalist in the 'Technology provider of the year' category is testament to the hard work of the IMS MAXIMS team in thinking outside the box to deliver agile solutions that meet the needs of the healthcare service.

"IMS MAXIMS prides itself on its responsiveness and ability to tailor its solutions to the individual needs of healthcare organisations as well as having a deep understanding of how technology can help address much wider issues. We very much look forward to the awards ceremony in June."

During 2012, IMS MAXIMS also began the development of its Da Vinci product, a cloud-based electronic health record for patients that will be supplemented by a number of mobile apps to give patients ownership and responsibility for their health record, potentially removing the need for hospitals to store such information on their own systems. IMS MAXIMS' innovative nature has been well recognised by a number of multinational corporations, recently resulting in securing a partnership with a global IT vendor.

Other key highlights include deploying full electronic patient record system to local charity, CancerCare, to support its staff and patients, as well as working alongside an NHS hospital trust to deploy the dementia system in order to help the trust diagnose and more efficiently treat patients with dementia, meanwhile meeting CQUIN requirements and payments.

The winners of the HealthInvestor Awards will be announced at a black-tie dinner at the Grosvenor House Hotel, Park Lane, London on Wednesday 12 June.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...